•  
  •  
  •  
  •  

2025-12-06 01:34:13

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Reliance Power Ltd clarifies on provisional attachment of assets by ED
  • Fino becomes India's first Payments Bank to receive 'In-principle' approval from RBI for conversion into a Small Finance Bank
  • Fire at Aditya Vision Ltd's warehouse
  • Shriram Pistons & Rings Ltd announces Definitive Agreement to acquire 100% stake in Antolin Group's Indian Operations
  • Supreme Petrochem Ltd announces temporary closure of plant at Manali, Chennai

Keywords Selected:  Inspection

Stock Report

  • Ipca Laboratories Ltd receives 3 observations from USFDA for API facility at Tarapur
  • Granules India's Packaging Facility in US Completes FDA inspection with Zero Observations
  • Glenmark Pharmaceuticals Ltd update on USFDA PAI at Chhatrapati Sambhajinagar Facility
  • Innoxel Lifesciences Successfully Completes EU GMP Inspection by Belgium's FAMHP
  • GMP Inspection by Ministry of Health, Armenia at Alkem's manufacturing facility located at Sikkim, India
  • Shilpa Medicare Ltd receives 8 observations from USFDA for Unit 4 at Jadcherla
  • Lupin Ltd receives 7 observations from USFDA for Goa manufacturing facility
  • NATCO Pharma Ltd receives 7 Observations from USFDA for API unit at Manali, Chennai
  • Solara announces successful closure of US FDA inspection of its Mangalore Facility with continued state of compliance on cGMP
  • Aurobindo Pharma gets 9 observations from USFDA for Unit 2 of Eugia Pharma Specialities Ltd
  • USFDA inspects Unit 1 of Divi's Laboratories Limited
  • Closure of USFDA inspection at Zydus' oncology injectable manufacturing facility in SEZ1, Ahmedabad
  • Lupin Bioresearch Center receives Zero Observations from U.S. FDA after Successful Inspection and Assessment
  • Innova Captab Limited updates on SMDC inspection
  • Biocon Limited updates on GMP inspection by USFDA at its Cranbury, New Jersey facility
  • Lupin gets one observation from USFDA for Somerset, New Jersey manufacturing facility
  • Emcure Pharmaceuticals Ltd completes surveillance inspection by USFDA without any observation
  • Zydus receives EIR for the oncology injectable manufacturing facility in SEZ1, Ahmedabad
  • Jubilant Pharmova announces Completion of Pharmacovigilance Inspection by the USFDA with No Observations
  • Lupin gets 4 observations from USFDA from PAI at Pune Biotech facility
  • USFDA successfully completes inspection at Indoco's API manufacturing facility at Patalganga with zero observations
  • Lupin receives 6 observations from USFDA for Nagpur Injectable facility
  • Tyche Industries Ltd completes GMP inspection by ANVISA
  • USFDA conducts product specific pre-approval inspection at Lupin Ltd's Aurangabad facility

Latest Post

  • Reliance Power Ltd clarifies on provisional attachment of assets by ED
  • Fino becomes India's first Payments Bank to receive 'In-principle' approval from RBI for conversion into a Small Finance Bank
  • Fire at Aditya Vision Ltd's warehouse
  • Shriram Pistons & Rings Ltd announces Definitive Agreement to acquire 100% stake in Antolin Group's Indian Operations
  • Supreme Petrochem Ltd announces temporary closure of plant at Manali, Chennai


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024